Navigation Links
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award
Date:11/13/2013

ion technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2012, our Form 10-Q for the quarter ended September 30, 2013, and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACTS:
Investors: Bernie Hertel, Inovio Pharmaceuticals, 858-410-3101 bhertel@inovio.com 
Media: Jeff Richardson, Inovio Pharmaceuticals, 267-440-4211, jrichardson@i
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. MVI and Inovio partner to develop malaria vaccines using innovative vaccine delivery tech
2. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
3. Scripps Research and Takeda Pharmaceuticals announce expanded research collaboration
4. Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever
5. Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis
6. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
7. AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms
8. Fish show autism-like gene expression in water with psychoactive pharmaceuticals
9. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
10. From scourge to saint: E. coli bacteria becomes a factory - to make cheaper, faster pharmaceuticals
11. Sanford-Burnham receives US Air Force grant to perform next-generation toxicity screens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 2, 2014 It is a great ... the appointment of the world-renowned Thoracic and Cardiovascular surgeon, ... Dr. Ginsburg, with over 34 years of ... Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg ... late 1980,s and is considered an expert in the ...
(Date:7/10/2014)... 3, 2014 Research and Markets ( ... "Global Gesture Recognition & Touch-Less Sensing (2D, ... 2020" report to their offering ... Recognition & Touch-Less Sensing Market to Grow Exponentially. ... while, but the companies were unable to leverage ...
(Date:7/10/2014)... , July 8, 2014 ... won a new design win (DW). An Asian OEM has ... for mass production start in August 2014.   ... smartphone OEM, which has a planned date for start of ... initial ramp order of SEK 5M, for delivery in the ...
Breaking Biology News(10 mins):Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
... children to eat their fruit and vegetables. But once ... often go the way of Barbie dolls and power ... fruits past adolescence. , Fisetin, a naturally occurring flavonoid ... stimulates signaling pathways that enhance long-term memory, report researchers ...
... UT Southwestern Medical Center experts warn that packing on pounds ... Americans who have diabetes and don't even know it. ... a silent killer because its symptoms aren't sudden, but build ... maladies. , That's bad news for those with undiagnosed ...
... archaeon capable of fixing nitrogen at a surprisingly hot ... earliest lineages of organisms capable of nitrogen fixation, perhaps ... animals rely on to fix nitrogen. , The ... Science supports the notion that the gene needed to ...
Cached Biology News:A natural chemical found in strawberries boosts memory in healthy mice 2A natural chemical found in strawberries boosts memory in healthy mice 3Holiday gluttony can spell disaster for undiagnosed diabetics 2Microbe fixes nitrogen at a blistering 92 C 2Microbe fixes nitrogen at a blistering 92 C 3
(Date:7/10/2014)... Terascala, the industry leader in ... a former vice president of product management for Flexera ... of marketing. Terascala’s software when combined with leading compute ... highest performance and most reliable solutions for processing big ... channel expansion and broaden its product portfolio. His leadership ...
(Date:7/10/2014)... OMICS Group’s 5th International conference and exhibition ... at Double Tree by Hilton Beijing, China is all ... & Bioanalytical research methods only to facilitate improved living ... Dr. Srinubabu Gedela, MD of OMICS Group Inc has ... one in bringing a unique and international mix of ...
(Date:7/10/2014)... , July 10, 2014  Franciscan ... use of capnography for respiratory monitoring outside ... of healthcare leaders in embracing state-of-the-art patient ... effectively patients are breathing and can alert ... By measuring the amount of carbon dioxide ...
(Date:7/10/2014)... , July 10, 2014 /PRNewswire-iReach/ -- ... and interpretation, today announced an agreement with ... analytics for Lineagen,s NextStep Dx PLUS.  ... neurodevelopmental and neurological disorders, currently offers FirstStep ... (CMA) testing service used by healthcare providers ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... BALTIMORE, May 16, 2012  In an effort to voice ... diseases (PIDD), the Immune Deficiency Foundation (IDF) offered oral ... Drug Administration (FDA) public hearing on draft guidance of ... (Ig) therapies from the biosimilars pathways in order to ...
... 12, 2011, nearly fifteen years after she became paralyzed and ... thinking about moving her arm and hand to lift a ... That achievement is one of the advances in brain-computer interfaces ... 17 edition of the journal Nature by the ...
... CENTERVILLE, Mass., May 16, 2012  UV Flu Technologies, ... announce that it has signed a television joint venture ... for the filming of a 60 second commercial, along ... locally, regionally, and nationally, on a variety of television ...
Cached Biology Technology:Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2People with paralysis control robotic arms to reach and grasp using brain computer interface 2People with paralysis control robotic arms to reach and grasp using brain computer interface 3People with paralysis control robotic arms to reach and grasp using brain computer interface 4People with paralysis control robotic arms to reach and grasp using brain computer interface 5UV Flu Technologies to Commence a National TV Advertising Campaign 2UV Flu Technologies to Commence a National TV Advertising Campaign 3
Immunogen: Human Respiratory Syncytial Virus (RSV) and Bovine Respiratory Syncytial Virus (BRSV) Fusion protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... Immunogen: Synthetic peptide derived from the ... protein. Specificity: Reacts with the ... Reactivity: Human Mouse (positive controls: WNT1-transfected ... lysates and mouse Mouse-1 cell lysates). ...
Biology Products: